A nonprofit that's helping train the future drug manufacturing workforce is opening its new space at the mixed-use Allston Labworks campus.

Sanofi licensed the antibody from Alopexx Pharmaceuticals, a precursor to the current biotech of the same name, in 2009 but faced challenges such as the slow enrollment (PDF) of a phase 2a trial.

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...

Detailed trial results could help Sanofi and Teva Pharmaceuticals make a case that a drug they’ve been developing will be competitive with rival treatments from Merck & Co. and Roche. The data, ...

We've identified the following companies as similar to Sanofi because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the virus that causes Covid-19. This virus hasn ...

Researchers at the Chinese lab accused of leaking the COVID-19 virus have now discovered a new coronavirus in bats that closely matches the one that led to the deadly worldwide outbreak in 2020 ...

Sanofi Consumer healthcare Indias standalone net profit fell ... inspection at the analytical testing facility of Sitec Labs, wholly owned subsidiary of the Company (Sitec) located in Mahape, Navi ...

As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced headcount at the contract research organization. As promised, the restructuring ...

Image credit: Shutterstock / Leitenberger Photography. Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement ...

Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as updates from Arcus Biosciences, Gilead Sciences and Ultragenyx Pharmaceutical that you might have missed.